Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 7, Pages 793-796Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14712598.2017.1333597
Keywords
Apolipoprotein A-I; biological therapy; gene therapy; high-density lipoproteins; reconstituted HDL; surrogate endpoint
Funding
- Onderzoekstoelagen grant of the KU Leuven [OT/13/090]
- Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G0A3114N]